(Updated - May 24, 2021 5:33 AM EDT)

Goldman Sachs analyst Brian Lee initiates coverage on StemCells (NYSE: STEM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE